Aberrant expression of PDGFRα has been identified in multiple types of human cancers, including medulloblastomas, papillary thyroid cancer, colorectal cancer, gliomas, liver cancer, and ovarian cancer10,30–35. Here, PDGFRA is linked to central nervous system cancer.